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Mice with type 2 diabetes manifest selective hepatic insulin resistance: insulin fails to suppress gluconeo-
genesis but continues to activate lipogenesis, producing the deadly combination of hyperglycemia and
hypertriglyceridemia. In this issue of Cell Metabolism, Biddinger et al. (2008) show that mice with total
hepatic insulin resistance exhibit hyperglycemia without hypertriglyceridemia—a state paradoxically less
severe than selective insulin resistance.Humans with type 2 diabetes mellitus ex-
hibit the classic triad of hyperinsulinemia,
hyperglycemia, and hypertriglyceridemia.
Hyperglycemia in the face of hyperinsuli-
nemia is attributed to insulin resistance.
In diabetic subjects, the major insulin-
resistant organs are liver, muscle, and
adipose tissue. The precise contribution
that each organ makes to hyperglycemia
and hypertriglyceridemia is not known.
To answer this question, Kahn and associ-
ates have conducted systematic studies
in mice in which they have ablated the
insulin receptor gene in each of these sus-
pect organs (Biddinger and Kahn, 2006).
The latest installment is found in this issue,
where Biddinger et al. (2008) examine glu-
cose and lipid metabolism in liver-specific
insulin receptor knockout (LIRKO) mice
(Michael et al., 2000). Biddinger et al. de-
scribe several disturbances of metabo-
lism in the LIRKO mice. Here, we focus
on the central issue of the insulin resis-
tance triad.
In their initial description of LIRKOmice,
Michael et al. (2000) reported that selec-
tive elimination of the insulin receptor in
livers of young mice produced both fast-
ing hyperglycemia and hyperinsulinemia.
Despite extremely high levels of circulat-
ing insulin, the mice exhibited marked hy-
perglycemia in response to an exogenous
glucose load and a diminished response
to injected insulin, consistent with sys-
temic insulin resistance.
Biddinger et al. (2008) explore the con-
sequences of hepatic insulin receptor de-
ficiency for the third element of the insulin
resistance triad, namely hypertriglyceri-
demia. Herein lies the paradox. In LIRKO
mice, the correlation with type 2 diabetes
breaks down. Despite hyperglycemia andhyperinsulinemia, LIRKO mice manifest
low plasma triglycerides and no elevation
of hepatic triglycerides.
The explanation for theparadox is found
in the dual actions of insulin in the liver,
as illustrated in Figure 1. As shown in Fig-
ure 1A, under normal conditions, dietary
glucose stimulates insulin secretion from
the pancreas. The insulin travels directly
to the livervia theportal vein,where it elicits
two key actions at the level of gene tran-
scription. First, insulin stimulates the phos-
phorylationof FoxO1, a transcription factor
that activates gluconeogenesis (Matsu-
moto et al., 2006). Insulin-stimulatedphos-
phorylation prevents FoxO1 from entering
the nucleus, and hence it downregu-
lates genes required for gluconeogenesis,
most prominently phosphoenolpyruvate
carboxykinase (PEPCK) and glucose 6-
phosphatase (G6Pase). The result is a de-
crease in hepatic glucose output, which
helps to keep blood glucose low.
The second action of insulin is to acti-
vate the transcription factor SREBP-1c,
which enhances transcription of genes
required for fatty acid and triglyceride bio-
synthesis, most prominently acetyl-coen-
zyme A carboxylase (ACC) and fatty acid
synthase (FAS) (Brown and Goldstein,
1997;Horton et al., 2002). Insulin activates
SREBP-1c by two mechanisms: (1) it in-
creases transcription of the SREBP-1c
gene, and (2) it increases the amount of
nuclear SREBP-1c,most likely by increas-
ing the conversion of the membrane-
bound precursor to its cleaved nuclear
form (Shimomura et al., 2000; Ferre and
Foufelle, 2007). The newly produced tri-
glycerides are secreted in very low-
density lipoprotein (VLDL), which delivers
triglycerides to fat for storage and toCell Metabolismuscle for combustion. Uptake of VLDL-
derived fatty acids in adipose tissue is
facilitated by insulin, which increases the
amount of lipoprotein lipaseon the surface
of endothelial cells.
Figure 1B shows how this regulatory
system goes awry in two mouse models
of insulin-resistant type 2 diabetes, ob/ob
mice and lipodystrophic mice, both of
which have increased food intake sec-
ondary to a deficiency of the appetite-
suppressant hormone leptin. Increased
food intake increases insulin secretion.
In the liver, the FoxO1 pathway becomes
insulin resistant. Despite extremely high
insulin levels, the mRNAs for PEPCK and
G6Pase remain high, and gluconeogene-
sis continues. Despite insulin resistance
in the FoxO1 pathway, insulin sensitivity is
maintained in the SREBP-1c pathway
(Shimomura et al., 2000). Thus, nuclear
SREBP-1c levels are extremely high, fatty
acid synthesis is accelerated, and triglyc-
erides accumulate in the liver. Excess tri-
glycerides are secreted in VLDL, raising
plasma triglyceride levels. Fatty acids de-
rived from these triglycerides worsen the
insulin-resistant state in muscle and adi-
pose tissue. The net result is the classic
type 2 diabetic triad—hyperglycemia, hy-
perinsulinemia, and hypertriglyceridemia.
Figure 1C shows how glucose and fatty
acid metabolism in LIRKO mice differs
from that in mouse models of type 2 dia-
betes. InLIRKOmice, food intake isnormal,
but hepatic insulin resistance is total. Insulin
cannot suppress gluconeogenesis, and
thus the liver continues to secrete glucose.
Insulin also cannot activateSREBP-1c, and
so hepatic triglycerides and circulating
VLDL are low. The net result is hyper-
insulinemia and hyperglycemia withoutm 7, February 2008 ª2008 Elsevier Inc. 95
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Previewshypertriglyceridemia. In their initial
paper, Michael et al. (2000) supplied
evidence that the hyperinsulinemia
in LIRKO mice results in part from
a failure of the receptor-deficient liver
to clear insulin from the circulation via
receptor-mediated endocytosis. In
the fasted state, the high systemic
insulin levelsdonotproducehypogly-
cemia, indicating that fat and muscle
are insulin resistant in LIRKO mice
despite the lack of hypertriglyceride-
mia. These observations are consis-
tent with the idea that hyperinsuline-
mia itself elicits insulin resistance in
peripheral tissues, as postulated 15
years ago (McGarry, 1992).
The concept of selective insulin
resistance in the liver assumes in-
creased importance with the realiza-
tion that elevated fatty acids and
triglycerides make detrimental contri-
butions to thediabeticstate.The foun-
dation for this concept was laid in
1992 with a prescient opinion piece
written by the late Denis McGarry en-
titled ‘‘What if Minkowski Had Been
Ageusic? An Alternative Angle on
Diabetes’’ (McGarry, 1992). McGarry
pointed out the toxic role played
by elevated VLDL triglycerides in pa-
tients with type 2 diabetes. In particu-
lar, he marshaled data showing that
some of these triglycerides deposit in
muscle, where they enhance insulin
resistance. Triglycerides also accu-
mulate in the liver, where they can
produce nonalcoholic steatohepatitis
(NASH), an increasingly frequent
cause of cirrhosis and liver failure.
Some of the excess triglycerides also
deposit in b cells of the pancreas,
where they contribute to the eventual
b cell failure that leads to frank dia-
betes (Unger, 1995). Lipotoxicity is
a term that has been coined to
designate the detrimental effects of
triglyceride accumulation in various
organs (Lee et al., 1994; Unger,
1995). Whether the toxic moieties are
fattyacids, triglycerides,orothercom-
pounds derived from fatty acids is not
settled. In this regard, it is of interest
that hyperglycemia declines in LIRKOmicewithage (Michael et al., 2000), afinding
opposite that observed inob/ob and lipody-
strophicmice. The lackof diabetesprogres-
sion in LIRKO mice might be attributable,
at least in part, to a lack of lipotoxicity.96 Cell Metabolism 7, February 2008 ª2008 EFrom a scientific standpoint, the para-
dox of selective insulin resistance raises
the question of the regulatory step inwhich
the gluconeogenic and lipogenic pathways
diverge. The effect of insulin on both path-lsevier Inc.ways requires the insulin receptor.
However, at some distal point, the
FoxO1 pathway becomes insensitive
to insulin, whereas the SREBP-1c
pathway remains sensitive. Identifi-
cation of this branch point is a central
question for future research.
In type 2 diabetes, selective insu-
lin resistance has implications for
therapy. By ‘‘brute force’’ treatment
of type 2 diabetes patientswith large
doses of insulin, we can overwhelm
the insulin resistance and control
the blood sugar, but at what price?
Is it possible that high doses of insu-
lin further enhance hepatic triglycer-
ide synthesis and increase lipotoxic-
ity? It seems preferable to search for
new agents that will improve insulin
sensitivity in the pathway that leads
to suppression of hepatic gluconeo-
genesis and enhanced peripheral
glucose uptake. With such an agent,
insulin levels should fall, hepatic
SREBP-1c levels should decline,
and lipotoxicity should be averted.
This lesson and several others may
be drawn from the recent studies of
the paradox of selective insulin
resistance in the liver.
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Unger, R.H. (1995). Diabetes 44, 863–870.Figure 1. Model Illustrating the Paradox by which
Selective Insulin Resistance in the Liver Produces
a More Severe Metabolic Defect than Total Insulin
Resistance
(A) Normal response of the liver to a glucose load. Insulin leads
to decreased gluconeogenesis and increased synthesis of
fatty acids and triglycerides (Tg).
(B) Selective insulin resistance in liver of mice with type 2
diabetes. Insulin fails to decrease gluconeogenesis, but it
continues to stimulate synthesis of fatty acids and Tg. This
produces the deadly combination of hyperglycemia and
hypertriglyceridemia.
(C) Total insulin resistance in liver of LIRKOmice. Insulin fails to
decrease gluconeogenesis, and it also fails to stimulate syn-
thesis of fatty acids and Tg. This leads to hyperglycemia with-
out hypertriglyceridemia, a state that may have consequences
less severe than those observed with the combined elevation.
